Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119426) titled 'A clinical study of pegylated interferon alfa-2b combined with Albuvirtide (ABT) for functional cure in HIV-1 infection' on Feb. 27.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Beijing Youan Hospital, Capital Medical University
Condition:
HIV-1 infection / AIDS-related condition: most participants are chronically HIV-infected individuals with virological suppression on ART. Potential related manifestations include impaired immune function (e.g., changes in CD4 count), increased risk of opportunistic infections, and systemic symptoms such as fatigue, weight loss, fever, diarrhe...